MetLife Investment Management’s Clover Health Investments CLOV Stock Holding History

MetLife Investment Management’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.29M	Buy	246,434 +41,082	+20%	+$139K	0.01%	1388
2026 Q1	$361K	Sell	205,352 -6,090	-3%	-$13.2K	﹤0.01%	1913
2025 Q4	$497K	Sell	211,442 -25,676	-11%	-$70.2K	﹤0.01%	1795
2025 Q3	$726K	Sell	237,118 -6,945	-3%	-$19.8K	﹤0.01%	1631
2025 Q2	$681K	Buy	+244,063	New	+$802K	﹤0.01%	1523
2023 Q2	–	Sell	-214,239	Closed	-$181K	–	2948
2023 Q1	$181K	Buy	214,239 +66,290	+45%	+$72.6K	﹤0.01%	2280
2022 Q4	$138K	Sell	147,949 -58,013	-28%	-$77.4K	﹤0.01%	2457
2022 Q3	$350K	Hold	205,962	–	–	﹤0.01%	1887
2022 Q2	$441K	Buy	+205,962	New	+$547K	﹤0.01%	1752

Other funds holding CLOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

MetLife Investment Management's CLOV Position: Q2 2026 in Review

MetLife Investment Management increased its Clover Health Investments (CLOV) stake by 20% in Q2 2026, buying an estimated $139K and bringing the position to 246,434 shares worth $1.29M. The position accounts for 0.01% of the portfolio, ranked #1388.

MetLife Investment Management first reported a position in CLOV in Q2 2022 and has held it in 9 quarters since. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

MetLife Investment Management held 246,434 shares of Clover Health Investments worth $1.29M as of Q2 2026.
MetLife Investment Management bought 41,082 Clover Health Investments shares in Q2 2026, an estimated $139K.
Clover Health Investments made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1388 holding.
MetLife Investment Management first reported a position in Clover Health Investments in Q2 2022 and has held it in 9 quarters since.
227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.